SECAUCUS, N.J., Oct. 4, 2023
/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the
world's leading provider of diagnostic information services,
announced that it will report third quarter 2023 financial results
on Tuesday, October 24, 2023, before
the market opens. It will hold its quarterly conference call to
discuss the results beginning at 8:30 a.m.
Eastern Time on that day.
The conference call can be accessed by dialing 888-455-0391
within the U.S. and Canada,
or 773-756-0467 internationally, using the passcode:
"7895081." The earnings release and live webcast will be posted on
www.QuestDiagnostics.com/investor. The company suggests
participants dial in approximately 10 minutes before the
call.
A replay of the call may be accessed online at
www.QuestDiagnostics.com/investor or by phone at 800-945-5759
for domestic callers or 203-369-3502 for international callers; no
passcode is required. Telephone replays will be available from
approximately 10:30 a.m. Eastern Time
on October 24, 2023 until
midnight Eastern Time on November 7, 2023.
Anyone listening to the call is encouraged to read the company's
periodic reports on file with the Securities and Exchange
Commission, including the discussion of risk factors and historical
results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived from the
world's largest database of clinical lab results, our diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors, and improve health care management. Quest
annually serves one in three adult Americans and half the
physicians and hospitals in the United
States, and our nearly 50,000 employees understand that, in
the right hands and with the right context, our diagnostic insights
can inspire actions that transform lives.
www.QuestDiagnostics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-third-quarter-2023-financial-results-on-october-24-2023-301947175.html
SOURCE Quest Diagnostics